1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Massachusetts >
  6. Absci Acquires Totient

M&A Deal Summary

Absci Acquires Totient

On June 15, 2021, Absci acquired life science company Totient from Viva Biotech Co.

Acquisition Highlights
  • This is Absci’s 2nd transaction in the Life Science sector.
  • This is Absci’s 2nd transaction in the United States.
  • This is Absci’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2021-06-15
Target Totient
Sector Life Science
Buyer(s) Absci
Sellers(s) Viva Biotech Co.
Deal Type Divestiture

Target

Totient

Cambridge, Massachusetts, United States
Totient is a discovery company harnessing human immune responses to identify novel antibodies and their therapeutic targets. Totient reconstructs antibodies from patients experiencing exceptional immune responses. Totient was founded in 2017 and is based in Cambridge, Massachusetts.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Absci

Vancouver, Washington, United States
Category Company
Founded 2011
Sector Life Science
Employees156
Revenue 4M USD (2024)
DESCRIPTION

Absci is a synthetic biology company enabling drug discovery and biomanufacturing of next-generation biotherapeutics. Absci patented SoluPro E. coli expression system and Protein Printing platform enable simultaneous creation of novel biotherapeutic drugs and the cell lines to manufacture them in a single efficient process. Absci was founded in 2011 and is based in Vancouver, Washington.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-12 Denovium

San Diego, California, United States

Denovium, Inc. is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology’s toughest questions. Denovium is based in San Diego, California.

Buy -

Seller(S) 1

SELLER

Viva Biotech Co.

Hong Kong, China
Category Company
Sector Life Science
DESCRIPTION

Viva Biotech (Shanghai) Co., Ltd. is structure-based, integrated drug discovery platform, providing structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development. Viva Biotech (Shanghai) is based in Hong Kong.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-09 Zhejiang Langhua Pharmaceutical Co.

Zhejiang, China

Zhejiang Langhua Pharmaceutical Co., Ltd is a comprehensive manufacturing enterprises focusing on API and intermediates production and CDMO projects. Zhejiang Langhua Pharmaceutical was founded in 1996 and is based in Zhejiang, China.

Buy HK$2.8B
Mergr

Solution for

Product

Company

Legal